Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...

President Donald Trump’s executive order on Day One of his administration to “deliver emergency price relief” doesn’t include ...

Major changes to Medicare drug pricing will bring relief to over 853,000 beneficiaries. So what's it really like inside a really cheap old house? This week I found out the truth behind the instagram ...

CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be ...

President Trump’s tariffs on China could increase drug prices and spur shortages across the U.S. as a trade war looms. NBC ...

Adam Colborn, JD, of AMCP, discusses the complexities of drug pricing and what policymakers must consider in efforts to ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...

A bill to stop Pharmacy Benefit Managers or PBMs from giving pharmacies less money than it costs to fill prescriptions advanced through the Iowa House Commerce Committee Tuesday.

The state refuted the argument that its prescription drug pricing transparency law compels pharmaceutical companies to disclose trade secrets.